You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Guide to Atopic Dermatitis: Clinical Pearls for Dermatologists and Allergists

  • Authors: Thomas Bieber, MD, PhD, MDRA; Lawrence F. Eichenfield, MD
  • CME / ABIM MOC Released: 11/8/2018
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/8/2019
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, allergists & clinical immunologists, and primary care physicians.

The goal of this activity is to inform clinicians regarding how accurate assessment of moderate to severe atopic dermatitis (AD), review of prior treatment response, and informed patient decision-making are important considerations when deciding if systemic treatment is an appropriate treatment option.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Assessment of patients to diagnose moderate-to-severe AD
    • Assessment of patients with moderate-to-severe AD to determine when treatment failure has occurred
  • Demonstrate improved performance associated with
    • Their ability to engage patients in shared decision making to formulate comprehensive treatment plans for AD and concomitant conditions


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Thomas Bieber, MD, PhD, MDRA

    Professor and Chair
    University of Bonn
    Bonn, Germany

    Disclosures

    Disclosure: Thomas Bieber, MD, PhD, MDRA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Allmir; AnaptysBio; Asana Biosciences; Astellas Pharma, Inc.; Celgene Corporation; Daiichi Sankyo, Inc.; Dermavant Sciences, Inc.; Galderma Laboratories, L.P.; Galapagos; GlaxoSmithKline; Glenmark; Kymab; LEO Pharma; Lilly; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi
    Served as a speaker or a member of a speakers bureau for: Astellas Pharma, Inc.; Dermavant Sciences, Inc.; LEO Pharma; Sanofi

    Dr Bieber does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Bieber does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Faculty

  • Lawrence F. Eichenfield, MD

    Professor of Dermatology and Pediatrics
    Chief
    Pediatric and Adolescent Dermatology
    Rady Children's Hospital
    University of California, San Diego School of Medicine, United States

    Disclosures

    Disclosure: Lawrence F. Eichenfield, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Allergan, Inc.; Anacor; DS Biopharma; Galderma Laboratories, L.P.; Genentech, Inc.; Lilly; Medimetriks; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Ralaxar; Regeneron Pharmaceuticals, Inc.; Sanofi; TopMD; Valeant Pharmaceuticals International;
    Served as a speaker or a member of a speakers bureau for: Valeant Pharmaceuticals International;
    Other: Investigator for Regeneron Pharmaceuticals, Inc.; Sanofi

    Dr Eichenfield does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Eichenfield does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Shari J. Dermer, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Shari J. Dermer, PhD has disclosed no relevant financial relationships.

  • Heather Lewin, MAT

    Associate Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Heather Lewin, MAT has disclosed no relevant financial relationships.

CME Reviewer

  • Esther Nyarko, PharmD

    Associate CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Guide to Atopic Dermatitis: Clinical Pearls for Dermatologists and Allergists

Authors: Thomas Bieber, MD, PhD, MDRA; Lawrence F. Eichenfield, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 11/8/2018

Valid for credit through: 11/8/2019

processing....

  • Print